epigenetic modifications Search Results


93
TargetMol chromatin modification compound library
Chromatin Modification Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromatin modification compound library/product/TargetMol
Average 93 stars, based on 1 article reviews
chromatin modification compound library - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
TargetMol sgc epigenetic compounds
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Sgc Epigenetic Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sgc epigenetic compounds/product/TargetMol
Average 94 stars, based on 1 article reviews
sgc epigenetic compounds - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
Epigenomics ag epigenomics/epigenetics pathways of histones modifications
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Epigenomics/Epigenetics Pathways Of Histones Modifications, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenomics/epigenetics pathways of histones modifications/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
epigenomics/epigenetics pathways of histones modifications - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag epigenetic modifications
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Epigenetic Modifications, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenetic modifications/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
epigenetic modifications - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag chromatin structure and epigenetic modification
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Chromatin Structure And Epigenetic Modification, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromatin structure and epigenetic modification/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
chromatin structure and epigenetic modification - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag epigenetic histone modifications data
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Epigenetic Histone Modifications Data, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenetic histone modifications data/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
epigenetic histone modifications data - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag epigenetic histone modifications data from nih roadmap epigenomics mapping consortium
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Epigenetic Histone Modifications Data From Nih Roadmap Epigenomics Mapping Consortium, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenetic histone modifications data from nih roadmap epigenomics mapping consortium/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
epigenetic histone modifications data from nih roadmap epigenomics mapping consortium - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag circulating tumor dnas epigenetic modifications
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Circulating Tumor Dnas Epigenetic Modifications, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/circulating tumor dnas epigenetic modifications/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
circulating tumor dnas epigenetic modifications - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Helmholtz Zentrum fur Infektionsforschung GmbH epigenetic modifications
High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including <t>SGC</t> <t>epigenetic</t> compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.
Epigenetic Modifications, supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenetic modifications/product/Helmholtz Zentrum fur Infektionsforschung GmbH
Average 90 stars, based on 1 article reviews
epigenetic modifications - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigen Biosciences epigenetic modifications and microbiota in the genesis of adipose tissue dysfunction and insulin resistance
( 1a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the placebo group. ( 1b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the probiotic treatment group. ( 1c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the fecal <t>microbiota</t> transplantation (FMT) group. ( 2a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the placebo group. ( 2b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the probiotic treatment group. ( 2c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the fecal microbiota transplantation (FMT) group.
Epigenetic Modifications And Microbiota In The Genesis Of Adipose Tissue Dysfunction And Insulin Resistance, supplied by Epigen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epigenetic modifications and microbiota in the genesis of adipose tissue dysfunction and insulin resistance/product/Epigen Biosciences
Average 90 stars, based on 1 article reviews
epigenetic modifications and microbiota in the genesis of adipose tissue dysfunction and insulin resistance - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Oxford Nanopore long read sequencing technology used for de novo genome assembly, isoform identification, and detecting epigenetic modifications.
Evaluating the pros and cons of selected sequencing and mapping technologies.
Long Read Sequencing Technology Used For De Novo Genome Assembly, Isoform Identification, And Detecting Epigenetic Modifications., supplied by Oxford Nanopore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/long read sequencing technology used for de novo genome assembly, isoform identification, and detecting epigenetic modifications./product/Oxford Nanopore
Average 90 stars, based on 1 article reviews
long read sequencing technology used for de novo genome assembly, isoform identification, and detecting epigenetic modifications. - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Epigenomics ag analysis of the global epigenetic state or modifications within an individual
Evaluating the pros and cons of selected sequencing and mapping technologies.
Analysis Of The Global Epigenetic State Or Modifications Within An Individual, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/analysis of the global epigenetic state or modifications within an individual/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
analysis of the global epigenetic state or modifications within an individual - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including SGC epigenetic compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.

Journal: bioRxiv

Article Title: Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer

doi: 10.64898/2026.04.16.719008

Figure Lengend Snippet: High-throughput drug screen and MEK inhibitor sensitivity in MRTX1719-resistant NSCLC cells. (A) Composition of the compound library used for drug screen, including SGC epigenetic compounds, FDA-approved oncology drugs, and TargetMol epigenetic inhibitors. (B) IC50 values of MRTX1719 and anisomycin in DMSO and MRTXR cells. Anisomycin was included as a nonselective control in the drug screen. (C) Dose-response curves of DMSO and MRTXR cells treated with the MEK inhibitor selumetinib. Data are presented as mean ± SD. (D) Synergy heatmaps of MRTX1719 and selumetinib in DMSO and MRTXR cells. Synergy mean scores were calculated using the Bliss model with the SynergyFinder+ tool.

Article Snippet: The screening library comprised 619 compounds, including SGC epigenetic compounds, TargetMol epigenetic inhibitors, and FDA-approved oncology drugs ( ).

Techniques: High Throughput Screening Assay, Drug discovery, Control

( 1a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the placebo group. ( 1b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the probiotic treatment group. ( 1c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the fecal microbiota transplantation (FMT) group. ( 2a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the placebo group. ( 2b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the probiotic treatment group. ( 2c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the fecal microbiota transplantation (FMT) group.

Journal: Nutrients

Article Title: Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance

doi: 10.3390/nu16203491

Figure Lengend Snippet: ( 1a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the placebo group. ( 1b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the probiotic treatment group. ( 1c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding glucose in the fecal microbiota transplantation (FMT) group. ( 2a ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the placebo group. ( 2b ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the probiotic treatment group. ( 2c ) Results of the 75 g oral glucose tolerance test (OTTG) regarding insulin in the fecal microbiota transplantation (FMT) group.

Article Snippet: This Phase II, randomized, single-blind, parallel-arm clinical trial was performed at Virgen de la Victoria University Hospital in Málaga (Spain), as a sub-study of the project “ Epigenetic modifications and microbiota in the genesis of adipose tissue dysfunction and insulin resistance ” (EPIGEN-MICROBIOTA), and was approved by our local Ethics Committee.

Techniques: Transplantation Assay

( a ) Number of bacteria species that were lost, maintained, or gained with respect to the baseline profile with each of the interventions: fecal microbiota transplant (FMT), probiotic intervention (PB), or placebo groups at 4 weeks or 12 weeks. ( b ) Within the FMT intervention, the number of bacteria species shared between the donor and the receptor, the number of species only found in the donor, and the number of species only found in the receptor of the intervention in relation to their respective donors at different time points.

Journal: Nutrients

Article Title: Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance

doi: 10.3390/nu16203491

Figure Lengend Snippet: ( a ) Number of bacteria species that were lost, maintained, or gained with respect to the baseline profile with each of the interventions: fecal microbiota transplant (FMT), probiotic intervention (PB), or placebo groups at 4 weeks or 12 weeks. ( b ) Within the FMT intervention, the number of bacteria species shared between the donor and the receptor, the number of species only found in the donor, and the number of species only found in the receptor of the intervention in relation to their respective donors at different time points.

Article Snippet: This Phase II, randomized, single-blind, parallel-arm clinical trial was performed at Virgen de la Victoria University Hospital in Málaga (Spain), as a sub-study of the project “ Epigenetic modifications and microbiota in the genesis of adipose tissue dysfunction and insulin resistance ” (EPIGEN-MICROBIOTA), and was approved by our local Ethics Committee.

Techniques: Bacteria

Evaluating the pros and cons of selected sequencing and mapping technologies.

Journal: Current opinion in insect science

Article Title: Recent Advances and Future Perspectives in Vector-omics

doi: 10.1016/j.cois.2020.05.006

Figure Lengend Snippet: Evaluating the pros and cons of selected sequencing and mapping technologies.

Article Snippet: Oxford Nanopore Technologies , Long read sequencing technology used for de novo genome assembly, isoform identification, and detecting epigenetic modifications. , Sequencing of long DNA molecules directly enable detection of epigenetic modifications. Can sequence transcripts for full cDNA and direct RNA sequencing for nucleotide modification detection. Length of reads are only limited by the DNA isolation and sequencing library. Sequencing devices are portable and scalable. Real time analysis is possible for rapid workflows. Several insect tissues have been sequenced showing promise for the vector field. Continuing community-guided improvements to chemistry , High error rate but can be corrected by overlap consensus. Sensitive to long homopolymers. Requires hands-on training to operate. Limited protocols for vectors. Constant updates to kits and user interface which make it challenging for comparison and to keep pace. , ~15 kb/2Mb* (in theory, read length is only limited by the DNA input).

Techniques: Sequencing, Plasmid Preparation, RNA Sequencing Assay, Modification, DNA Extraction, Comparison, Scaffolding, Variant Assay, Produced, Immunoprecipitation, Genome Wide, Expressing, Binding Assay, Activity Assay, Amplification